This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Companies in this article
ARTES Biotechnology announced the acquirement of the ANAVAX virus-like particle (VLP) technology from Select Vaccines Ltd. ANAVAX is a patent-protected VLP technology that can be applied to the prevention of several infectious diseases.
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.